- Home
- SYRE vs EXP Comparison
SYRE vs EXP Comparison
Compare SYRE & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | EXP |
|---|---|---|
| Founded | 2013 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.0B |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SYRE | EXP |
|---|---|---|
| Price | $107.33 | $198.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | $85.08 | ★ $227.11 |
| AVG Volume (30 Days) | ★ 794.3K | 427.2K |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.29 |
| Revenue | N/A | ★ $495,023,000.00 |
| Revenue This Year | N/A | $1.97 |
| Revenue Next Year | N/A | $1.95 |
| P/E Ratio | ★ N/A | $62.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.51 | $171.99 |
| 52 Week High | $110.18 | $245.53 |
Technical Indicators
Market Signals| Indicator | SYRE | EXP |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 41.74 |
| Support Level | $93.45 | $188.79 |
| Resistance Level | N/A | $226.04 |
| Average True Range (ATR) | 4.53 | 5.78 |
| MACD | -0.09 | -0.81 |
| Stochastic Oscillator | 87.74 | 0.00 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.